NOBIO LTD

General Data

supplementary funding
Reg Number
515281285
Sector
Biomed
Established
2015
No. of Employees
27
Stage
Initial Revenues
Additional Funding
1

Description

Antibacterial technology of a submicron particle additive that makes the final product resistant to bacteria for a very long time. The activity of the product is not based on the excretion of the antibacterial component into the environment and does not c

Technology

Novel nano-particles incorporated into common materials (like an additive) and transforms them to highly anti-microbial, indefinitely. Nobio’s breakthrough technology uniquely combines strength, longevity and safety. When encountering bacteria or virus, the Nobio particles exert strong, concentrated electrostatic stress, causing their breakdown and death. The particles are non-soluble and their mode of action does not require any chemical release or exchange, so they remain active indefinitely, without affecting the surroundings. The novel particles consist of a solid core and a high concentration of covalently-bound functional molecules, which multiplies the antimicrobial effect. The solid core enables to permanently embed the particles in the bulk of the treated material, or anchor it to its surface, to provide strong and long-lasting protection.

Targeted Customers

Dental Industry, Medical Devices and Implants, Food Packaging, Consumer & Industrial products.

Management personnel

Natan Zaltsman - CTO

Contact information

Name
Website
http://www.nobio.com
Country
Israel
Zip
6092000

Tags

AdditivesAdvanced MaterialsBiofilmBiologicalsBiotechnologyDentalFoodTechImplantsInfectious DiseasesLife SciencesMedTech

Classified Technologies

Chemistry and Materials

Winning details

Route name
Winning year

R&D Program
R&D Program
2023
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023